Asset 1

Healthtech & Digital health

Our tech and life sciences teams provide seamless expert advice for global companies and investors in the fast-growing digital health industry. Our clients are renowned investors, from prominent early-stage funds to the largest global venture capital firms, and ambitious global digital health companies who, with our support, are revolutionizing the industry.

Through our established investor network we create transformative funding solutions for clients at all business stages, creating substantial financial foundations for growth and on-going development.

With experts in the UK, Europe, the Middle East, and Asia, together with our key partner collaborations in the US, our specialist approach in the provision of finance and capital raising, regulatory and data privacy, and IP, coupled with cross border expertise, provides the foundations for significant and sustainable global expansion for our clients. Our comprehensive awareness of the regulatory challenges facing emerging digital health companies both internally, and among ecosystem partners, is invaluable.

Supported by our data privacy and security teams, we successfully resolve personal data issues particular to digital and app-based devices and the broader regulatory challenges faced by our clients within a rapidly changing industry.

Similarly, our highly regarded IP team helps digital health companies achieve important milestones by securing, developing, and protecting valuable IP assets. This includes restructuring and executing sophisticated agreements and collaborations, partnerships and licensing agreements, and acquiring and divesting valuable businesses through strategic M&A.

Healthtech & Digital Health

A new era for digital health in Germany

10. Dezember 2020
Briefing

von Thanos Rammos, LL.M.

Klicken Sie hier für Details
Healthtech & Digital Health

Das Krankenhauszukunftsgesetz

7. Dezember 2020
Klicken Sie hier für Details
Datenschutz & Cyber-Sicherheit

Global Data Hub - Health data

27. November 2020
Quick read

von mehreren Autoren

Klicken Sie hier für Details
Employment, Pensions & Mobility

Helen Farr discusses the use of the NHS COVID-19 App at work for life sciences businesses with European Pharmaceutical Review

2. November 2020

von Helen Farr

Klicken Sie hier für Details

Events

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.